From HIV to Inflammation: How RNA Biology Redefined Drug Discovery
• Obefazimod pioneers RNA biogenesis modulation as a therapeutic strategy. • Small molecules can stabilize RNA–protein complexes such as CBC–ARS2 to enhance microRNA production. • The CBC–ARS2–miR-124 axis links RNA metabolism to immune homeostasis. • HIV RNA splicing studies unexpectedly revealed an inflammation-control mechanism. • Pharmacological tuning of host RNA pathways inaugurates a new class of small-molecule immunomodulators.
Authors
- Jamal Tazi (ORCID: https://orcid.org/0000-0002-1949-8748)
Institutions
- Centre National de la Recherche Scientifique (FR)
- Institut de Génétique Moléculaire de Montpellier (FR)
Publication Details
- Journal
- Drug Discovery Today
- Published
- 2025-11-16
- DOI
- https://doi.org/10.1016/j.drudis.2025.104530
- Primary Topic
- RNA Research and Splicing
- Type
- article
- Field-Weighted Citation Impact
- 0.00